These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24184894)

  • 1. Safety of very early sheath removal in patients treated with REG1 for acute coronary syndromes: insights from the RADAR trial.
    Vavalle JP; Povsic TJ; Aberle LH; Zelenkofske SL; Mehran R; Kasprzak JD; Bode C; Buller CE; Montalescot G; Cornel JH; Becker RC; Alexander JH; Cohen MG
    J Invasive Cardiol; 2013 Nov; 25(11):593-9. PubMed ID: 24184894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safety of variable anticoagulation reversal using the REG1 system in patients with acute coronary syndromes: results of the RADAR trial.
    Povsic TJ; Vavalle JP; Aberle LH; Kasprzak JD; Cohen MG; Mehran R; Bode C; Buller CE; Montalescot G; Cornel JH; Rynkiewicz A; Ring ME; Zeymer U; Natarajan M; Delarche N; Zelenkofske SL; Becker RC; Alexander JH;
    Eur Heart J; 2013 Aug; 34(31):2481-9. PubMed ID: 22859796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bleeding complications in patients with acute coronary syndrome undergoing early invasive management can be reduced with radial access, smaller sheath sizes, and timely sheath removal.
    Cantor WJ; Mahaffey KW; Huang Z; Das P; Gulba DC; Glezer S; Gallo R; Ducas J; Cohen M; Antman EM; Langer A; Kleiman NS; White HD; Chisholm RJ; Harrington RA; Ferguson JJ; Califf RM; Goodman SG
    Catheter Cardiovasc Interv; 2007 Jan; 69(1):73-83. PubMed ID: 17139670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of anticoagulation regimens on sheath management and bleeding in patients undergoing elective percutaneous coronary intervention in the STEEPLE trial.
    Gallo R; Steinhubl SR; White HD; Montalescot G;
    Catheter Cardiovasc Interv; 2009 Feb; 73(3):319-25. PubMed ID: 19213086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fondaparinux with UnfracTionated heparin dUring Revascularization in Acute coronary syndromes (FUTURA/OASIS 8): a randomized trial of intravenous unfractionated heparin during percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes initially treated with fondaparinux.
    Steg PG; Mehta S; Jolly S; Xavier D; Rupprecht HJ; Lopez-Sendon JL; Chrolavicius S; Rao SV; Granger CB; Pogue J; Laing S; Yusuf S
    Am Heart J; 2010 Dec; 160(6):1029-34, 1034.e1. PubMed ID: 21146654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the REG1 anticoagulation system in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the phase II RADAR-PCI study.
    Povsic TJ; Vavalle JP; Alexander JH; Aberle LH; Zelenkofske SL; Becker RC; Buller CE; Cohen MG; Cornel JH; Kasprzak JD; Montalescot G; Fail PS; Sarembock IJ; Mehran R;
    EuroIntervention; 2014 Aug; 10(4):431-8. PubMed ID: 24929350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bivalirudin versus unfractionated heparin during percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndrome initially treated with fondaparinux: results from an international, multicenter, randomized pilot study (SWITCH III).
    Waksman R; Bertrand O; Driesman M; Gruberg L; Rossi J; Mehta S; Swymelar S; Dvir D; Xue Z; Torguson R
    J Interv Cardiol; 2013 Apr; 26(2):107-13. PubMed ID: 23240743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and rationale for the Minimizing Adverse haemorrhagic events by TRansradial access site and systemic Implementation of angioX program.
    Valgimigli M;
    Am Heart J; 2014 Dec; 168(6):838-45.e6. PubMed ID: 25458646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, partially blinded, multicenter, active-controlled, dose-ranging study assessing the safety, efficacy, and pharmacodynamics of the REG1 anticoagulation system in patients with acute coronary syndromes: design and rationale of the RADAR Phase IIb trial.
    Povsic TJ; Cohen MG; Mehran R; Buller CE; Bode C; Cornel JH; Kasprzak JD; Montalescot G; Joseph D; Wargin WA; Rusconi CP; Zelenkofske SL; Becker RC; Alexander JH
    Am Heart J; 2011 Feb; 161(2):261-268.e1-2. PubMed ID: 21315207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of timing of clopidogrel treatment on the efficacy and safety of bivalirudin in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention: an analysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.
    Lincoff AM; Steinhubl SR; Manoukian SV; Chew D; Pollack CV; Feit F; Ware JH; Bertrand ME; Ohman EM; Desmet W; Cox DA; Mehran R; Stone GW;
    JACC Cardiovasc Interv; 2008 Dec; 1(6):639-48. PubMed ID: 19463378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter randomized trial comparing a percutaneous collagen hemostasis device with conventional manual compression after diagnostic angiography and angioplasty.
    Sanborn TA; Gibbs HH; Brinker JA; Knopf WD; Kosinksi EJ; Roubin GS
    J Invasive Cardiol; 1999 Sep; 11 Suppl B():6B-13B. PubMed ID: 10745611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of safety and efficacy of bivalirudin versus unfractionated heparin in high-risk patients undergoing percutaneous coronary intervention (from the Anti-Thrombotic Strategy for Reduction of Myocardial Damage During Angioplasty-Bivalirudin vs Heparin study).
    Patti G; Pasceri V; D'Antonio L; D'Ambrosio A; Macrì M; Dicuonzo G; Colonna G; Montinaro A; Di Sciascio G
    Am J Cardiol; 2012 Aug; 110(4):478-84. PubMed ID: 22583760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized comparative study of using enoxaparin instead of unfractionated heparin in the intervention treatment of coronary heart disease.
    Chen JL; Chen J; Qiao SB; Guo YL; Wu YJ; Dai J; Yuan JQ; Qin XW; Yang YJ; Gao RL
    Chin Med J (Engl); 2006 Mar; 119(5):355-9. PubMed ID: 16542576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial.
    White HD; Kleiman NS; Mahaffey KW; Lokhnygina Y; Pieper KS; Chiswell K; Cohen M; Harrington RA; Chew DP; Petersen JL; Berdan LG; Aylward PE; Nessel CC; Ferguson JJ; Califf RM
    Am Heart J; 2006 Dec; 152(6):1042-50. PubMed ID: 17161049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of bivalirudin in patients receiving clopidogrel therapy after diagnostic angiography for percutaneous coronary intervention in acute coronary syndromes.
    Feldman DN; Minutello RM; Bergman G; Moussa I; Wong SC
    Catheter Cardiovasc Interv; 2010 Oct; 76(4):513-24. PubMed ID: 20882655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First clinical application of an actively reversible direct factor IXa inhibitor as an anticoagulation strategy in patients undergoing percutaneous coronary intervention.
    Cohen MG; Purdy DA; Rossi JS; Grinfeld LR; Myles SK; Aberle LH; Greenbaum AB; Fry E; Chan MY; Tonkens RM; Zelenkofske S; Alexander JH; Harrington RA; Rusconi CP; Becker RC
    Circulation; 2010 Aug; 122(6):614-22. PubMed ID: 20660806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose vs standard-dose unfractionated heparin for percutaneous coronary intervention in acute coronary syndromes treated with fondaparinux: the FUTURA/OASIS-8 randomized trial.
    ; Steg PG; Jolly SS; Mehta SR; Afzal R; Xavier D; Rupprecht HJ; López-Sendón JL; Budaj A; Diaz R; Avezum A; Widimsky P; Rao SV; Chrolavicius S; Meeks B; Joyner C; Pogue J; Yusuf S
    JAMA; 2010 Sep; 304(12):1339-49. PubMed ID: 20805623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin formation and effect of unfractionated heparin during pediatric cardiac catheterization.
    Chen D; Långström S; Petäjä J; Heikinheimo M; Pihkala J
    Catheter Cardiovasc Interv; 2013 Jun; 81(7):1174-9. PubMed ID: 22915548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic use of a collagen-based vascular closure device immediately after cardiac catheterization procedures in 1,317 consecutive patients.
    Eggebrecht H; Haude M; Woertgen U; Schmermund A; von Birgelen C; Naber C; Baumgart D; Kaiser C; Oldenburg O; Bartel T; Kroeger K; Erbel R
    Catheter Cardiovasc Interv; 2002 Dec; 57(4):486-95. PubMed ID: 12455083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unfractionated heparin use after percutaneous coronary intervention: results of a trial with a vascular ultrasound endpoint.
    Juergens CP; Crozier JA; Robinson JT; Lo S; French JK; Leung DY
    Heart Lung Circ; 2008 Apr; 17(2):107-13. PubMed ID: 17913583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.